J.J. Body

Zoledronic Acid Is Superior to Pamidronate in the Treatment of Hypercalcemia of Malignancy: A Pooled Analysis of Two Randomized, Controlled Clinical Trials

Pierre Major, Alain Lortholary, Jeremy K. Hon et al. · Journal of Clinical Oncology · 2001 · 857 citations

Medicine, Pharmacology, Pharmacotherapy +10

Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial

David L. Kendler, Fernando Marín, Cristiano A. F. Zerbini et al. · The Lancet · 2017 · 581 citations · Full text

Medicine, Endocrinology, Gynecology +15

Practical guidance for the management of aromatase inhibitor-associated bone loss

Peyman Hadji, J.J. Body, Matti Aapro et al. · Annals of Oncology · 2008 · 226 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +14

Extended Efficacy and Safety of Denosumab in Breast Cancer Patients with Bone Metastases Not Receiving Prior Bisphosphonate Therapy

Allan Lipton, Guenther G. Steger, Jazmín Meneses Figueroa et al. · Clinical Cancer Research · 2008 · 161 citations · Full text

Medicine, Oncology, Pharmacology +17

A Dose-Finding Study of Zoledronate in Hypercalcemic Cancer Patients

J.J. Body, Alain Lortholary, Gilles Romieu et al. · Journal of Bone and Mineral Research · 1999 · 151 citations · Full text

Pharmacy, Oncology, Pharmacology +13